- Home
- NEXM vs SGMO Comparison
NEXM vs SGMO Comparison
Compare NEXM & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEXM | SGMO |
|---|---|---|
| Founded | N/A | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.5M | 135.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | NEXM | SGMO |
|---|---|---|
| Price | $3.89 | $0.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.60 |
| AVG Volume (30 Days) | 69.8K | ★ 4.2M |
| Earning Date | 02-20-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $32,875,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.37 | $0.38 |
| 52 Week High | $10.35 | $1.40 |
Technical Indicators
Market Signals| Indicator | NEXM | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 38.99 |
| Support Level | $3.76 | $0.43 |
| Resistance Level | $4.22 | $0.48 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 36.96 | 8.32 |
Price Performance
Historical ComparisonAbout NEXM NexMetals Mining Corp.
NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.